Page last updated: 2024-08-22

clodronic acid and Chronic Kidney Diseases

clodronic acid has been researched along with Chronic Kidney Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hu, Z; Pei, G; Zeng, R; Zhan, J1
Beneke, A; Burzlaff, N; Daniel, C; Eckardt, KU; Goppelt-Struebe, M; Herrmann, M; Jantsch, J; Kalucka, J; Katschinski, DM; Klanke, B; Mayer, M; Palsson, R; Schatz, V; Schley, G; Thorsteinsdottir, M; Weidemann, A; Willam, C1

Other Studies

2 other study(ies) available for clodronic acid and Chronic Kidney Diseases

ArticleYear
Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI-CKD transition.
    Renal failure, 2023, Volume: 45, Issue:1

    Topics: Acute Kidney Injury; Animals; Clodronic Acid; Cytokines; Fibrosis; Interleukin-10; Liposomes; Macrophages; Mice; Mice, Inbred C57BL; Renal Insufficiency, Chronic; Reperfusion Injury; Transforming Growth Factor beta

2023
Mononuclear phagocytes orchestrate prolyl hydroxylase inhibition-mediated renoprotection in chronic tubulointerstitial nephritis.
    Kidney international, 2019, Volume: 96, Issue:2

    Topics: Adenine; Animals; Anti-Inflammatory Agents; Basic Helix-Loop-Helix Transcription Factors; Clodronic Acid; Complement C1q; Disease Models, Animal; Glycine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isoquinolines; Kidney Tubules; Male; Mice; Mice, Transgenic; Nephritis, Interstitial; Phagocytes; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Protective Agents; Renal Insufficiency, Chronic

2019